Acelrx Pharmaceuticals reported $507K in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US USD 507K 63K
Baxter International BAX:US USD 3.77B 27M
Becton, Dickinson and BDX:US USD 4.59B 175M
Cara Therapeutics CARA:US USD 10.81M 12.19M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
Johnson & Johnson JNJ:US USD 23.71B 85M
Pfizer PFE:US USD 24.29B 1.65B
Smiths SMIN:LN GBP 1.37B 182M
Teva Pharmaceutical TEVA:IT USD 3.6B 191M
Xeris Pharmaceuticals Inc XERS:US USD 29.72M 4.42M